Disorders of consciousness

N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences

mycolabadmin

Researchers studied how DMT, a powerful psychedelic drug, changes brain activity patterns and how these changes relate to what people experience. Using advanced brain imaging and network analysis, they found that DMT shifts brain activity away from large-scale network patterns toward smaller, more diverse patterns. Importantly, these brain changes directly tracked with how intensely participants reported experiencing the drug’s effects moment-to-moment.

A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics

mycolabadmin

Psychedelic compounds like psilocybin and ketamine show promise in treating serious mental health conditions including PTSD and depression. The FDA carefully evaluates these drugs through multi-phase clinical trials to ensure they are safe and effective. While California has proposed making psychedelics more widely available through legislation, the FDA’s thorough approval process provides important protections by identifying potential risks and ensuring proper medical oversight.

Disease: Disorders of consciousness

N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences

A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics